- Published at
- by gurufocus.com
neutral
neutral
Labcorp Announces 2025 First Quarter Results
PR NewswireBURLINGTON, N.C., April 29, 2025
Updates Full-Year GuidanceResults from Operations for first quarter 2025 versus first quarter last year:Revenue
News for Invitae Corporation (NVTA)
- Published at
- by globenewswire.com
mixedmixedNanomedicine Market to Hit USD 634.2 Billion by 2032; Improvements in Drug Delivery and Therapeutics Witness Rising Momentum
With rising chronic disease rates and increasing collaboration between pharmaceutical companies and academia, the nanomedicine market is poised for...- Published at
- by investing.com
positivepositiveBaird boosts Laboratory Corporation of America stock target, retains Outperform By Investing.com
Baird boosts Laboratory Corporation of America stock target, retains Outperform- Published at
- by globenewswire.com
positivepositivePress release Biocartis NV: Biocartis appoints renowned
PRESS RELEASE - 13/08/2024, 16:00 CEST Biocartis appoints renowned precision oncology expert, Dr. W. Michael Korn, as Chief Medical and Scientific Officer...- Published at
- by gurufocus.com
positivepositiveDecoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight
Labcorp's expansive test portfolio and recent acquisitions bolster its market position.Legal challenges and regulatory scrutiny pose potential risks to operati- Published at
- by investing.com
positivepositiveLabcorp beats Q2 profit and revenue estimates on demand for health tests By Reuters
Labcorp beats Q2 profit and revenue estimates on demand for health tests- Published at
- by insidermonkey.com
neutralneutralInvitae Corporation (NVTAQ): A Good Stock to Buy and Hold According to Cathie Wood?
We recently compiled a list of the 10 Best Stocks to Buy and Hold For 5 Years According to Cathie Wood.- Published at
- by globenewswire.com
mixedmixedGlobal Precision Oncology Market Size To Exceed USA 260.5 Billion By 2033 | CAGR Of 10.21%
The Global Precision Oncology Market Size was Valued at USD 98.5 Billion in 2023 and the Worldwide Precision Oncology Market Size is Expected to Reach USD...- Published at
- by investing.com
neutralneutralNew Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines By Investing.com
New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines- Published at
- by investing.com
mixedmixedEarnings call: GeneDx reports 51% revenue surge, eyes profitability by 2025 By Investing.com
Earnings call: GeneDx reports 51% revenue surge, eyes profitability by 2025- Published at
- by investing.com
positivepositiveLabcorp Announces Winning Bid for Select Assets of Invitae By Investing.com
Labcorp Announces Winning Bid for Select Assets of Invitae- Published at
- by investing.com
mixedmixedLabcorp to acquire Invitae assets for $239 million By Investing.com
Labcorp to acquire Invitae assets for $239 million- Published at
- by marketscreener.com
mixedmixedInvitae Enters into Agreement with Labcorp for Sale of Business
– Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantially All of the...- Published at
- by globenewswire.com
neutralneutral[Latest] Global Hereditary Cancer Testing Market Size/Share Worth USD 12.1 Billion by 2033 at a 7.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, G
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Hereditary Cancer...- Published at
- by investing.com
mixedmixedInvitae gets court approval for five-month bankruptcy sale By Reuters
Invitae gets court approval for five-month bankruptcy sale- Published at
- by globenewswire.com
mixedmixedMultiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
PALM BEACH, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Recent reports show that the Multiple myeloma Diagnostic market will...- Published at
- by globenewswire.com
mixedmixedGenomic Cancer Testing is projected to Hit $45.92 Billion, Globally, by 2030 at 16.1% CAGR: Coherent Market Insights
Genomic cancer testing is a medical diagnostic process that involves analyzing the DNA of cancer cells to identify specific mutations, rearrangements, or...- Published at
- by insidermonkey.com
mixedmixed- Published at
- by prnewswire.com
mixedmixedPrecision Medicine Takes Center Stage: Innovative Report Explores the Role of Companion Diagnostics in Transforming Healthcare
/PRNewswire/ -- The "Companion Diagnostic Markets - the Future of Diagnostics by Application, Technology and Funding With Executive and Consultant Guides...- Published at
- by globenewswire.com
mixedmixedGlobal Hereditary Genetic Testing Market Size to Reach USD 66.11 Billion in 2030 | Emergen Research
Rising demand for direct-to-consumer genetic testing for developing personalized medicine specifically targeted to individuals is one of the major factors...